Cargando…
Malignant Adenomyoepithelioma of the Breast and Responsiveness to Eribulin
Adenomyoepithelioma (AME) of the breast is an uncommon tumor characterized by its dual differentiation into luminal cells and myoepithelial cells. In most cases these tumors have a benign clinical course, but distant metastases have been reported. We present the case of a 51-year-old woman diagnosed...
Autores principales: | Lee, Suee, Oh, Sung Yong, Kim, Sung-Hyun, Lee, Ji Hyun, Kim, Dae Cheul, Cho, Se Heon, Lee, Miri, Kim, Hyo-Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Breast Cancer Society
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705093/ https://www.ncbi.nlm.nih.gov/pubmed/26770248 http://dx.doi.org/10.4048/jbc.2015.18.4.400 |
Ejemplares similares
-
Ultrasonographic Features of Benign Adenomyoepithelioma of the Breast
por: Lee, Ji Hye, et al.
Publicado: (2010) -
Malignant adenomyoepithelioma of the breast
por: Moro, Kazuki, et al.
Publicado: (2020) -
Clinicopathological characteristics and outcomes of malignant adenomyoepithelioma of the breast: a single institution’s experience
por: Alqudaihi, Heba Mohammad Abdulla, et al.
Publicado: (2022) -
Malignant adenomyoepithelioma of the breast: A rare case report
por: Kim, Mi Jin, et al.
Publicado: (2019) -
Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results
por: Park, Yeon Hee, et al.
Publicado: (2017)